MedTrace Logo

Non-Interventional Enhanced Active Surveillance Study of Adults Vaccinated With AZD1222

NCT04877743 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 27

Last updated 2022-06-30

No results posted yet for this study

Summary

This is a Phase IV real-world, observational, non-interventional, prospective cohort study of adults vaccinated with AZD1222. The purpose of this study is to assess the safety and tolerability of AZD1222 in adults vaccinated in real-world settings.

Conditions

  • Coronavirus Disease 2019 (COVID-19)

Interventions

OTHER

None (Observational study)

The main data sources for the study will be participants and their medical records. Vaccination details will be verified by a vaccination card, batch/lot number, and/or using a regional vaccination register. Participants will report all study outcomes using the study app, web portal, or call centre. Participants can also select a proxy to communicate on their behalf: a caregiver, family member, or other trusted individual. Participants will be asked for an emergency contact in case of death or incapacity.

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Max Age
130 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-31
Primary Completion
2021-11-24
Completion
2021-11-24

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04877743 on ClinicalTrials.gov